Products for Research Use Only
RegisterLogin

SKLB 1028

CAT: 0013-GTR19192622-01Size: 1 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0013-GTR19192622-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
SKLB 1028 (Ruserontinib) is an oral multikinase inhibitor targeting EGFR, FLT3, and Abl kinases. It demonstrates potent efficacy in FLT3-driven acute myeloid leukemia (AML) models in vitro and in vivo, and shows significant activity against chronic myeloid leukemia (CML) models harboring Abl mutations.
CAS Number
1350544-93-2
Product Name Alternative
BcrAbl, Abl, EGFR, FLT3, SKLB1028, SKLB-1028, SKLB 1028, Ruserontinib
Field of Research
Cardiovascular Research, Signal Transduction
Purity
99.71% (May vary between batches)
Solubility
DMSO:50 mg/mL (112.73 mM)
Smiles
C (C) (C) N1C=2C (N=C1NC=3C=CC=NC3) =CN=C (NC4=CC=C (C=C4) N5CCN (C) CC5) N2
Molecular Formula
C24H29N9
Molecular Weight
443.55
Storage Conditions
-20°C
Notes
For research use only.

Related Products

CatalogName
GTR19280539-01SKLB-0124
GTR19158279-01SKLB-23bb
GTR19258231-01SKLB-D18
GTR19231918SKLB-03176
GTR19272971-01SKLB-Y13
GTR19263351-01SKLB-11A
GTR19257669-01SKLB-03220
GTR19173677-01SKLB-163
GTR19173145-01SKLB 610
GTR19169476-01SKLB-23bb

Alternative Products

CatalogName
TRC-S555010-250MGSKLB-1028
T34656-01SKLB 1028
HY-148122NW 1028
MBS5812227LC-1028
QXC58006-01SKLB-23bb
BUP10703-01SKLB 610
M27829-01SKLB-163
C03652-1gSKLB-11A
C01495-5mgSKLB-197

Popular Products